July 30, 2014 10:08 PM ET

Biotechnology

Company Overview of Genaera Corp.

Executive Profile

Mitchell A. Lazar M.D., Ph.D.

Member of Scientific Advisory Board, Genaera Corp.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Mitchell A. Lazar, M.D., Ph.D. serves as Director of the Institute for Diabetes, Obesity, and Metabolism and Chief of the Division of Endocrinology, Diabetes, and Metabolism at the University of Pennsylvania School of Medicine. Mr. Lazar is the Sylvan Eisman Professor of Medicine at the University of Pennsylvania School of Medicine. Dr. Lazar has been Member of Scientific Advisory Board of Genaera Corp. since September 10, 2007. Dr. Lazar has been elected to the American ...

Corporate Headquarters

5110 Campus Drive
Plymouth Meeting, Pennsylvania 19462

United States

Phone: 610-941-4020
Fax: 610-941-5399

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genaera Corp., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.